LymphedemaV1, PubMed, Checkpoint, bibRecord, 001617

Clinical features of docetaxel chemotherapy-related lymphedema.

Identifieur interne : 001617 ( PubMed/Checkpoint ); précédent : 001616; suivant : 001618

Clinical features of docetaxel chemotherapy-related lymphedema.

Auteurs : Sae In Park [Corée du Sud] ; Woo Hyun Jeon ; Ho Joong Jeung ; Ghi Chan Kim ; Dong Kyu Kim ; Young-Joo Sim

Source :

Lymphatic research and biology [ 1557-8585 ] ; 2014.

RBID : pubmed:25144149

Descripteurs français

KwdFr :
- Adulte d'âge moyen, Antinéoplasiques d'origine végétale (effets indésirables), Antinéoplasiques d'origine végétale (usage thérapeutique), Association thérapeutique, Femelle, Humains, Lymphoedème (), Taxoïdes (effets indésirables), Taxoïdes (usage thérapeutique), Tumeurs du sein (), Tumeurs du sein (traitement médicamenteux).
MESH :
- effets indésirables : Antinéoplasiques d'origine végétale, Taxoïdes.
- traitement médicamenteux : Tumeurs du sein.
- usage thérapeutique : Antinéoplasiques d'origine végétale, Taxoïdes.
- Adulte d'âge moyen, Association thérapeutique, Femelle, Humains, Lymphoedème, Tumeurs du sein.

English descriptors

KwdEn :
- Antineoplastic Agents, Phytogenic (adverse effects), Antineoplastic Agents, Phytogenic (therapeutic use), Breast Neoplasms (drug therapy), Breast Neoplasms (surgery), Combined Modality Therapy, Female, Humans, Lymphedema (chemically induced), Middle Aged, Taxoids (adverse effects), Taxoids (therapeutic use).
MESH :
- chemical , adverse effects : Antineoplastic Agents, Phytogenic, Taxoids.
- chemical , therapeutic use : Antineoplastic Agents, Phytogenic, Taxoids.
- chemically induced : Lymphedema.
- drug therapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- Combined Modality Therapy, Female, Humans, Middle Aged.

Abstract

Lymphedema is a chronic, progressive, and multifactorial disease. The anticancer drug docetaxel (Taxotere) can lead to fluid retention, which is the main cause of peripheral edema of the extremities, pleural effusion, pericardial effusion, and ascites in patients undergoing chemotherapy. While there have been a few case reports documenting fluid retention-induced edema as a side effect of docetaxel, it is not yet clear whether docetaxel causes lymphedema directly. Here, we report cases of three patients who developed lymphedema after treatment with docetaxel.

DOI: 10.1089/lrb.2013.0037
PubMed: 25144149

Affiliations:

Corée du Sud

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 001369
to stream PubMed, to step Curation: 001369

Links to Exploration step

pubmed:25144149

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical features of docetaxel chemotherapy-related lymphedema.</title>
<author><name sortKey="Park, Sae In" sort="Park, Sae In" uniqKey="Park S" first="Sae In" last="Park">Sae In Park</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine , Busan, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine , Busan</wicri:regionArea>
<wicri:noRegion>Busan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jeon, Woo Hyun" sort="Jeon, Woo Hyun" uniqKey="Jeon W" first="Woo Hyun" last="Jeon">Woo Hyun Jeon</name>
</author>
<author><name sortKey="Jeung, Ho Joong" sort="Jeung, Ho Joong" uniqKey="Jeung H" first="Ho Joong" last="Jeung">Ho Joong Jeung</name>
</author>
<author><name sortKey="Kim, Ghi Chan" sort="Kim, Ghi Chan" uniqKey="Kim G" first="Ghi Chan" last="Kim">Ghi Chan Kim</name>
</author>
<author><name sortKey="Kim, Dong Kyu" sort="Kim, Dong Kyu" uniqKey="Kim D" first="Dong Kyu" last="Kim">Dong Kyu Kim</name>
</author>
<author><name sortKey="Sim, Young Joo" sort="Sim, Young Joo" uniqKey="Sim Y" first="Young-Joo" last="Sim">Young-Joo Sim</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25144149</idno>
<idno type="pmid">25144149</idno>
<idno type="doi">10.1089/lrb.2013.0037</idno>
<idno type="wicri:Area/PubMed/Corpus">001369</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001369</idno>
<idno type="wicri:Area/PubMed/Curation">001369</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001369</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001369</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001369</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical features of docetaxel chemotherapy-related lymphedema.</title>
<author><name sortKey="Park, Sae In" sort="Park, Sae In" uniqKey="Park S" first="Sae In" last="Park">Sae In Park</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine , Busan, Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine , Busan</wicri:regionArea>
<wicri:noRegion>Busan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jeon, Woo Hyun" sort="Jeon, Woo Hyun" uniqKey="Jeon W" first="Woo Hyun" last="Jeon">Woo Hyun Jeon</name>
</author>
<author><name sortKey="Jeung, Ho Joong" sort="Jeung, Ho Joong" uniqKey="Jeung H" first="Ho Joong" last="Jeung">Ho Joong Jeung</name>
</author>
<author><name sortKey="Kim, Ghi Chan" sort="Kim, Ghi Chan" uniqKey="Kim G" first="Ghi Chan" last="Kim">Ghi Chan Kim</name>
</author>
<author><name sortKey="Kim, Dong Kyu" sort="Kim, Dong Kyu" uniqKey="Kim D" first="Dong Kyu" last="Kim">Dong Kyu Kim</name>
</author>
<author><name sortKey="Sim, Young Joo" sort="Sim, Young Joo" uniqKey="Sim Y" first="Young-Joo" last="Sim">Young-Joo Sim</name>
</author>
</analytic>
<series><title level="j">Lymphatic research and biology</title>
<idno type="eISSN">1557-8585</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents, Phytogenic (adverse effects)</term>
<term>Antineoplastic Agents, Phytogenic (therapeutic use)</term>
<term>Breast Neoplasms (drug therapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphedema (chemically induced)</term>
<term>Middle Aged</term>
<term>Taxoids (adverse effects)</term>
<term>Taxoids (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Antinéoplasiques d'origine végétale (effets indésirables)</term>
<term>Antinéoplasiques d'origine végétale (usage thérapeutique)</term>
<term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Taxoïdes (effets indésirables)</term>
<term>Taxoïdes (usage thérapeutique)</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents, Phytogenic</term>
<term>Taxoids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Agents, Phytogenic</term>
<term>Taxoids</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques d'origine végétale</term>
<term>Taxoïdes</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antinéoplasiques d'origine végétale</term>
<term>Taxoïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema is a chronic, progressive, and multifactorial disease. The anticancer drug docetaxel (Taxotere) can lead to fluid retention, which is the main cause of peripheral edema of the extremities, pleural effusion, pericardial effusion, and ascites in patients undergoing chemotherapy. While there have been a few case reports documenting fluid retention-induced edema as a side effect of docetaxel, it is not yet clear whether docetaxel causes lymphedema directly. Here, we report cases of three patients who developed lymphedema after treatment with docetaxel.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25144149</PMID>
<DateCreated><Year>2014</Year>
<Month>09</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>05</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>09</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8585</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>12</Volume>
<Issue>3</Issue>
<PubDate><Year>2014</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Lymphatic research and biology</Title>
<ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical features of docetaxel chemotherapy-related lymphedema.</ArticleTitle>
<Pagination><MedlinePgn>197-202</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1089/lrb.2013.0037</ELocationID>
<Abstract><AbstractText>Lymphedema is a chronic, progressive, and multifactorial disease. The anticancer drug docetaxel (Taxotere) can lead to fluid retention, which is the main cause of peripheral edema of the extremities, pleural effusion, pericardial effusion, and ascites in patients undergoing chemotherapy. While there have been a few case reports documenting fluid retention-induced edema as a side effect of docetaxel, it is not yet clear whether docetaxel causes lymphedema directly. Here, we report cases of three patients who developed lymphedema after treatment with docetaxel.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName>
<ForeName>Sae In</ForeName>
<Initials>SI</Initials>
<AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine , Busan, Korea.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jeon</LastName>
<ForeName>Woo Hyun</ForeName>
<Initials>WH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Jeung</LastName>
<ForeName>Ho Joong</ForeName>
<Initials>HJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Ghi Chan</ForeName>
<Initials>GC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kim</LastName>
<ForeName>Dong Kyu</ForeName>
<Initials>DK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sim</LastName>
<ForeName>Young-Joo</ForeName>
<Initials>YJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>08</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Lymphat Res Biol</MedlineTA>
<NlmUniqueID>101163587</NlmUniqueID>
<ISSNLinking>1539-6851</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D043823">Taxoids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>15H5577CQD</RegistryNumber>
<NameOfSubstance UI="C067311">docetaxel</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000972" MajorTopicYN="N">Antineoplastic Agents, Phytogenic</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D043823" MajorTopicYN="N">Taxoids</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>8</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>5</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25144149</ArticleId>
<ArticleId IdType="doi">10.1089/lrb.2013.0037</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Corée du Sud</li>
</country>
</list>
<tree><noCountry><name sortKey="Jeon, Woo Hyun" sort="Jeon, Woo Hyun" uniqKey="Jeon W" first="Woo Hyun" last="Jeon">Woo Hyun Jeon</name>
<name sortKey="Jeung, Ho Joong" sort="Jeung, Ho Joong" uniqKey="Jeung H" first="Ho Joong" last="Jeung">Ho Joong Jeung</name>
<name sortKey="Kim, Dong Kyu" sort="Kim, Dong Kyu" uniqKey="Kim D" first="Dong Kyu" last="Kim">Dong Kyu Kim</name>
<name sortKey="Kim, Ghi Chan" sort="Kim, Ghi Chan" uniqKey="Kim G" first="Ghi Chan" last="Kim">Ghi Chan Kim</name>
<name sortKey="Sim, Young Joo" sort="Sim, Young Joo" uniqKey="Sim Y" first="Young-Joo" last="Sim">Young-Joo Sim</name>
</noCountry>
<country name="Corée du Sud"><noRegion><name sortKey="Park, Sae In" sort="Park, Sae In" uniqKey="Park S" first="Sae In" last="Park">Sae In Park</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001617 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001617 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:25144149
   |texte=   Clinical features of docetaxel chemotherapy-related lymphedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:25144149" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Clinical features of docetaxel chemotherapy-related lymphedema.

Clinical features of docetaxel chemotherapy-related lymphedema.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki